In Singapore, experts seek solutions for the rising burden of osteoporosis in Asia-Pacific

November 04, 2016

The burden of osteoporosis in the Asia-Pacific region is expected to surge in the coming decades. Countries such as Singapore, Japan and Korea are among the high-risk countries for osteoporosis related fractures. Throughout the region, and particularly in China, a vast elderly population will drive a huge rise in the socio-economic burden of the disease. In fact, it is expected that by 2050 more than half of the world's hip fractures will occur in Asia.

Faced with this epidemic of fractures, close to 800 health professionals from more than 45 countries will gather today in Singapore for the opening of the International Osteoporosis Foundation (IOF) Regionals 6th Asia-Pacific Osteoporosis Meeting. The Meeting is organized by IOF in cooperation with the Endocrine and Metabolic Society of Singapore (EMSS) and the Osteoporosis Society Singapore (OSS). As Guest of Honour, Dr Amy Khor, Senior Minister of State for Ministry of Environment and Water Resources and the Ministry of Health of Singapore, will present the welcome address.

Meeting Co-Chair Dato' Dr Joon-Kiong Lee, Chair of the Asia Pacific/South Africa Regional Advisory Council of International Osteoporosis Foundation (IOF), President, Osteoporosis Awareness Society of Kuala Lumpur and Selangor (OASKLS), Malaysia and Consultant Orthopaedic Surgeon, Assunta Hospital/Beacon Hospital Petaling Jaya, Malaysia, said:

"The burden of fractures and health care costs for managing them are rising exponentially in the Asia Pacific region. Prevention spans the entire life-course, starting in the womb with good maternal nutrition, and extending to falls and fracture prevention in the very elderly. If we all take concerted action to prevent fractures, including secondary fractures in the most high-risk individuals, we can reduce the human and socioeconomic burden of fractures in the Asia Pacific region."

Further highlights will include the presentation of five IOF Young Investigator Awards for outstanding research, and a special session addressing successful approaches for integrated care within the scope of Non Communicable Diseases, co-hosted by IOF and the NCD Alliance.

In addition, the importance of integrating orthopaedic and medical care to improve the standard of care and primary management of patients suffering from osteoporosis will be recognized during the Opening Ceremony through the joint IOF and Asia-Pacific Orthopaedic Association (APOA) Working Group.

As Chair of the Local Organizing Committee, Dr Siok-Bee Chionh, Senior Consultant in the Division of Endocrinology, University Medicine Cluster, National University Hospital, stated:

"This meeting will bring together researchers and clinicians from around the region working in the fields of prevention and management of bone loss, muscle loss, falls and fractures, all of which are important issues affecting the rapidly-ageing populations of Singapore and many other Asian countries. We look forward to the state-of-the-art presentations that will improve our efforts to promote not just longevity but healthy ageing in older people."

Dr Manju Chandran, Scientific Programme Committee Co-chair, Director and Senior Consultant, Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital also stated:

"We are facing a tsunami of Diabetes and Osteoporosis in the Asia Pacific Region. In less than 10 years, the number of type 2 diabetes patients in South East Asia is estimated to be more than 80 million and by the year 2050, half the world's osteoporotic hip fractures are predicted to occur in Asia. Most people may not know or think of fragility fractures as a complication associated with diabetes. The CME-accredited scientific programme will include the latest research on the management of osteoporosis in diabetes, as well as cover other important aspects of osteoporosis prevention and management, rare side effects of medications, sarcopenia, secondary fracture prevention, and novel treatments."

The IOF Regionals will be held at the Singapore Convention & Exhibition Centre from November 4-6, 2016. Abstracts from the meeting will be published in Osteoporosis International, Volume 27, Suppl. 3, 2016.
-end-
Media contact

Rhonda Ng, Asia-Pacific Regional Manager, International Osteoporosis Foundation
rng@iofbonehealth.org Tel.: +65 6496 5508

IOF Regionals 6th Asia-Pacific Osteoporosis Meeting:

Organized by IOF in cooperation with the Endocrine and Metabolic Society of Singapore (EMSS) and the Osteoporosis Society Singapore (OSS), the 6th Asia-Pacific Osteoporosis Meeting is being held in Singapore from November 4-6, 2016 at the SUNTEC Singapore International Convention & Exhibition Centre. The IOF Regionals have been a key educational and research forum in the Asia-Pacific region since 2010. Past Meetings have been held in Taipei, Hong Kong, Kuala Lumpur, Australia, and Singapore. http://www.iofbonehealth.org/singapore-2016

About IOF:

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 234 patient, medical and research societies in 99 locations, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth@iofbonehealth

International Osteoporosis Foundation

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.